Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to no-option individuals suffering from angina, ...
Researchers uncovered how lung cells decide whether to rebuild tissue or fight infection. This built-in “switch” may be the ...
The Chronic Obstructive Pulmonary Disease Pipeline report embraces in-depth commercial and clinical assessment of the ...
Asianet Newsable on MSN
Scientists Reveal Lung Self-Healing Switch, Offering Hope for Chronic Lung Disease
Scientists uncover a molecular “switch” in lung cells that controls repair vs. defense. Targeting it could boost tissue ...
Mayo Clinic researchers have identified a molecular "switch" in lung cells that helps them decide when to repair tissue and ...
Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T ...
An international workshop of scientists, regulators, and industry experts led by Prof Ivana Barbaric convened to address the risks of genetic mutations in stem cell therapy. Human pluripotent stem ...
The brain's mechanisms for repairing injuries caused by trauma or degenerative diseases are not yet known in detail. Now, a ...
News-Medical.Net on MSN
New AI-driven approach identifies treatments to reprogram and destroy cancer stem cells
Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells – hard-to-find cells that help cancers spread, come back after treatment and resist ...
More than 4 million people worldwide have end-stage kidney disease that requires hemodialysis, a treatment in which a machine filters waste from the blood. Hemodialysis is a precursor to kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback